摘要
目的探讨舒利迭联合穴位敷贴对慢阻肺稳定期老年患者淀粉样蛋白A(SAA)水平影响。方法选取2022年6月—2022年11月白银市第一人民医院收治的200例慢性阻塞性肺疾病(COPD)稳定期老年患者作为研究对象,应用抽签法将其分为观察组(n=100)与对照组(n=100)。对照组患者应用舒利迭吸入治疗,观察组患者应用舒利迭联合穴位敷贴治疗,比较两组患者治疗前后中医证候积分水平、肺功能及SAA表达水平,并采用圣乔治呼吸问卷(SGRQ)评估治疗前后的生活质量。结果治疗后,观察组胸闷、气促、咳痰、咳嗽相关中医证候积分低于对照组,差异有统计学意义(P<0.05);治疗后,观察组FVC、FEV1、FEV1/FVC、PEF高于对照组,SAA低于对照组,差异有统计学意义(P<0.05);治疗后,观察组疾病影响、活动受限、呼吸症状及SGRQ总分低于对照组,差异有统计学意义(P<0.05)。结论舒利迭联合穴位敷贴对慢阻肺稳定期老年患者治疗效果显著,可减轻患者相关症状,提升肺功能,降低SAA表达水平,提升患者生活质量。
Objective To explore the eff ect of Shulidie combined with acupoint application on the levels of amyloid A(SAA)in elderly patients with stable chronic obstructive pulmonary disease(COPD).Methods 200 stable elderly patients with chronic obstructive pulmonary disease(COPD)admitted to Baiyin First People's Hospital from June 2022 to November 2022 were selected as the study subjects.They were divided into an observation group and a control group using a random number table method,with 100 cases in each group.The control group patients were treated with inhalation of suletide,while the observation group patients were treated with suletide combined with acupoint application.The TCM syndrome score,lung function,and SAA expression levels of the two groups of patients were compared before and after treatment,and the quality of life before and after treatment was evaluated using the St.George's Respiratory Questionnaire(SGRQ).Results After treatment,the TCM syndrome scores related to chest tightness,shortness of breath,phlegm,and cough in the observation group were lower than those in the control group(P<0.05);After treatment,the FVC,FEV1,FEV1/FVC,and PEF in the observation group were higher than those in the control group,while SAA was lower than those in the control group(P<0.05);After treatment,the observation group had lower disease impact,limited activity,respiratory symptoms,and SGRQ total score than the control group(P<0.05).Conclusion The combination of Suletide and acupoint application has a signifi cant therapeutic eff ect on elderly patients with stable chronic obstructive pulmonary disease,which can alleviate related symptoms,improve lung function,reduce SAA expression levels,and improve patient quality of life.
作者
王琼
WANG Qiong(Department of Geriatrics,Baiyin First People's Hospital,Baiyin Gansu 730900,China)
出处
《中华养生保健》
2024年第8期27-30,共4页
CHINESE HEALTH CARE
关键词
舒利迭
沙美特罗替卡松气雾剂
穴位敷贴
慢性阻塞性肺疾病
稳定期
淀粉样蛋白A
Suletide
Salmeterol and fl uticasone aerosol
acupoint application
chronic obstructive pulmonary disease
stable period
Amyloid protein A
